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ABSTRACT 
Skin is an attractive route for drug delivery. However poor permeation of drugs across the skin due to the presence of extremely ordered 
architecture of outermost layer of skin, led to several investigation to improve the permeability of drugs. Polysaccharides remain widely studied 
biomaterial for the sustained delivery of drug molecules across the skin. The advance of hyaluronic acid (HA) chemistry with multiple benefits 
has improved the attention of research groups for its application in the skin transportation of drug molecules. Beginning from the advantages of 
transdermal route, the present review details the application of HA in transdermal drug delivery. In the last few decades, substantial 
investigation in the domain has improved the requirement for an outline of all the developments, which is depicted in the review. The review 
also presented different types of HA based transdermal devices such as transferosomes, nanoemulsions, microneedle etc and their potential to 
improve the transdermal drug delivery. Furthermore the application of HA through chemical modification as a potential transdermal device is 
also presented.  
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Skin, the largest and easily approachable organ of the human 
body, is an excellent gateway for the delivery of therapeutic 
molecules. transdermal delivery offers avoidance of first pass 
hepatic metabolism, possibility of self-administration, 
painless drug administration, easy termination of therapy and 
improved patient’s compliances 1. However the unique 
architecture of skin furnishes a barrier to the drug molecules, 
limiting the practical application of transdermal route 2. A 
research group in 1924 reported that the outermost layer of 
skin called stratum corneum (SC), of approximately 15 µm 
thickness is the principal barrier to the drug transport 3. 
Further investigation disclosed that certain drug molecules 
possessed remarkable skin penetration, which led to the 
development of transdermal devices 4. For transdermal 
therapy to be potential, the drug molecules have to reach the 
vasculature in desired amounts to generate a therapeutic 
effect. Presently several transdermal devices are employing to 
overcome skin barrier function. This article discussed the 
application of HA in the development of transdermal drug 
delivery system.  
HA is a linear biodegradable polymer discovered in 1934 by 
Karl Meyer and John Palmer in the vitreous body of the cattle 
eye. It is an anionic, unbranched, non-sulfated glycosamino 
glycan consisted of alternating units of D-glucoronic acid and 
N-acetyl-D-glucosamine linked by β(1,4) and β(1,3) glycosidic 
bonds. HA naturally occurs in the extracellular matrix of 
connective tissues, dermal layer of skin, vitreous humor of eye 
and synovial fluids of joints 5. The physiological function of HA 
includes tissue repairing, wound healing, maintains tissue 
hydrodynamics, acts as a lubricant in muscular connective 
tissues etc.  
HA’s immunoneutrality brands it as a fascinating building 
constituent for biomaterials to be utilized for biomedical 
applications including drug delivery, tissue engineering etc. 
The imporatant physicochemical characteristics that grant to 
its success in opthalmologic surgery is the semiflexible 
behavior of the biodegradable HA chains. The shear thinning 
property of HA solutions ultimately results in the reduction of 
viscosity as the molecules allign in the streamlines of flow. 
This response makes HA simple to handle while pushing them 
through medical needles 5. HA can be chemically conjugated to 
drug carriers or directly to therapeutic molecules. The 
carboxylic and primary hydroxyl moities present in HA 
furnish favorable sites for chemical modifications. The 
primary hydroxyl moities allows esterification and 
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etherification while carboxylic moities permits ester and 
amide bond formation 6. The most remarkable benefit is the 
facile association of therapeutic molecules with the 
biopolymer which avoids problems associated with solubility. 
Furthermore HA enhances half-life of drugs in blood plasma 
and possess tumor targeting ability 6.  
HA is an fascinating platform for transdermal drug delivery. 
The transdermal application of HA moisturize the surface of 
skin which assists the transdermal absorption of therapeutic 
molecules and can promote the retention of these molecules 
in the comparitatively hydrated epidermal layers 7. Yang et al 
detailed that HA possess the capacity to disrupt and 
penetrates skin layers and cotransport the therapeutic 
molecules across the skin 8. The skin penetration 
enhancement of HA is due to the synergistic effect of co-
transport mechanism, hydration of skin and its interaction 
with keratin architecture of skin  7. However for the 
development of effective transdermal drug delivery system 
based on HA, several chemical and physical modification are 
required. The details of these modification and the capaity of 
hyaluronic acid to transport several drugmolecules are 
elucidated below.  
HA based transdermal drug delivery systems 
El Refaie et al prepared a transdermal system, gel-core 
hyalurosome to improve the skin transportation of curcumin 
for wound healing 9. The curcumin loaded gel-core 
hyalurosome was fabricated using thin film evaporation 
strategy. The dry film obtained from Lipoid S100 and Tween 
80 was hydrated with HA followed by the loading of curcumin. 
In vivo study disclosed that the application of the developed 
device in rat burn-wounds resulted in its swift healing 
ascribed to the anti-inflammatory effect of curcumin, in 
addition to the effect of HA. The device could enhance the skin 
transportation of curcumin, securing it against metabolism, 
hence improving the bioavailability. 
Lim et al prepared a hydrogel nanoparticle by the crosslinking 
reaction of HA and polyethylene glycol 10. The research group 
identified that the device displayed different capacity to 
permeate into skin depending on the nature of dispersion 
medium. Compared to hydrogel dispersed in an oil-in-water 
emulsion, that dispersed in oil or an oil composition showed 
better results. They reported that if the hydrogel carried drug 
molecules, it might release the drug by expanding its volume 
by the uptake of water present in the surface of skin. The 
enhanced water uptake is ascribed to the feature of HA.  
Wei et al employed HA as matrix of nanocrystal based 
hydrogel and evaluated its capacity to enhance the 
transdermal delivery of Baicalin 11. The hydrogel comprising 
of 1.0 % HA displayed that the highest gelation ability and 
thinning shear rheological properties. In vitro permeation test 
revealed a significant improvement in the permeation of 
Baicalin from HA based hydrogel compared to that of coarse 
gel. Cilurzo et al studied the permeation behavior of HA and 
their sulfates across the skin 12. The permeation test revealed 
that the sulfated HA permeated efficiently than corresponding 
HA. However the skin permeability was significantly reduced 
when the molecular mass of the polymer was increased. They 
also reported that HA possessed remarkable affinity for 
corneocytes and hence permeate chiefly through the 
transcellular route. The molecular dynamics analysis 
indicated that the increase in permeability of the studied 
polysaccharide was ascribed to their ability to assume flexible 
and extended conformations.  
Franze et al fabricated a transdermal system based on HA 
decorated liposomes for the delivery of nifedipine 13. They 
prepared liposome formulations by thin film hydration 
method using egg phosphatidylcholine, Tween 80 and 
nifedipine. The obtained lipid film was hydrated using HA-1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine conjugate. 
The outcomes disclosed that the presence of HA in the device 
played a remarkable role in the potential penetration of 
liposomes. But the presence of HA notably influenced the 
flexibility of the device ascribed to the enhanced lipid chain 
packing. However the vesicle fluidity play a key role in 
enhancing the skin permeation which counters balanced the 
stiffening effect. When HA is incorporated to vesicle in co-
administration, HA penetrate first into the skin layers, filling 
the holes for the diffusion of liposomes.   
Gao et al enhanced the transdermal delivery of 10,11-
Methylenedioxycamptothecin using HA nanoemulsions 14 
Glycerol α-monostearate was conjugated to HA and the HA 
nanoemulsion with hydrophobic interior and hydrophilic 
interfaces was obtained through oil/water/surfactant 
emulsifying system and solvent evaporation. The device 
displayed an excellent entrapment efficiency of about 81.81 
%. The fluorescence microscope images confirmed that HA 
nanoemulsion efficiently permeate through the epimermis 
and then into the dermal region. In vitro skin permeation test 
revealed that compared to control, HA nanoemulsion 
significantly improved the transdermal delivery of 10,11-
Methylenedioxycamptothecin. The increased permeability of 
HA nanoemulsion is ascribed to the potential of HA to 
enhance skin peneatration via transdermal hydration gradient 
and from high lipid hydration energy. The article reported 
that the developed device has the capacity to be employed for 
keloid therapy. 
Kong et al studied the stability of HA based nanoemulsion and 
its capacity as transdermal device 15. HA was modified with 
glycerol-α-monostearate and the nanoemulsion was prepared 
by oil/water/surfactant emulsifying system and solvent 
evaporation. The article reported that the stability of 
nanoemulsion was increased in presence of cross-linking 
agent, controlling the degree of substitution and modification 
of HA. The electrostatic, hydrophobic and steric effect 
involved a crucial part in the nanoemulsion stability. 
Furthermore, surfactants are main modulators to stabilize the 
colloidal interface. The device was also shown to efficiently 
encapsulate lipophilic molecules. In another article Kong et al 
reported the potential of the oil/water HA nanoemulsion to 
transport α-tocopherol across the skin 16 In vitro skin 
permeation test revealed that the developed nanoemulsion 
efficiently penetrate into deeper skin layers without any aid of 
penetration enhancers. Histological examination confirmed 
the security of the patch and they stated that the device 
enhanced the skin permeation without causing any skin 
irritation 
A nanographene oxide-HA conjugate was developed by Jung 
et al for the photothermal ablation therapy of melanoma skin 
cancer using near infrared laser 17. In vitro bioimaging and 
confocal imaging undoubtedly revealed the significant 
transdermal delivery of the prepared device to tumour cells, 
attributed to the over expressed HA receptors and 
comparatively leaky structures around tumor cells, permitting 
the improved penetration and detention of nanoparticles. The 
application of near infrared radiation produced total ablation 
of cancer cells without any recurrence of tumor genesis. The 
antitumor effect of the device was verified by histological 
assay, ELISA for caspase-3 activity and immune histochemical 
TUNEL assay. 
Kim et al developed a potential transdermal vaccination by 
using two essential innovations: the utilization of HA as 
carrier for vaccine and non-ablative laser adjuvants 18. 
Fluorescence assay and intravital microscopy confirmed that 
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HA conjugated ovalbumin vaccine patch could efficiently 
permeate into deeper layers of porcine and murine skins. The 
transdermal application of device remarkably improved the 
mucosal and humoral antibodies. Significant sturdy 
immunization was obtained with less doses of HA complex 
when pre-treated the skin using non-ablative laser beams. All 
the test outcomes suggested the capacity of the developed 
device for transdermal vaccination. 
Kong et al prepared biocompatible doxorubicin encapsulated 
HA based transferosome for tumor metastasis therapy 19. 
Amphiphilic HA obtained by the modification of HA with 
glycerol-α-monostearate was assembled on the 
transferosome. The in vitro test showed that the skin 
penetration of the prepared device was three times more than 
the solution. Furthermore, in vivo test revealed that the device 
led to remarkably greater accumulation in lymph nodes. The 
prepared transferosome significantly improved the endo-
cytosis of breast tumor cells, producing nine times greater 
cellular uptake compared to pristine transferosome.   Kong 
et al fabricated HA based niosome for transdermal tumor 
therapy 20. HA was modified with monostearin and the 
resulting amphiphilic HA was self-assembled on the surface of 
niosome. The developed device had around 40 nm size, 
excellent stability and enhanced drug encapsulation 
efficiency. In vivo skin penetration test revealed that the 
nanocarrier diffused into deeper dermal layer after 8 h of 
application. HA accumulated around hair follicles and even 
penetrated throughout the aqueous surrounding of epidermis 
and dermis. The device displayed more endocytosis to mouse 
breast tumor cell than the control (Chitosan). The 
investigation of histological section proved the potential and 
security of skin penetration. 
Kim et al developed a temperature sensitive transdermal 
device based on HA 21. They synthesized double cross-linked 
interpenetrating polymer network hydrogels consisted of HA 
and poly(N-isopropyl acrylamide) and evaluated their 
capacity to deliver luteolin across the skin for the treatment of 
psoriasis. The hydrogel synthesized from 3 % crosslinker 
displayed the highest stability. The drug release was found to 
be maximum at 25 0C and pH 5.5. The release of luteolin was 
induced by non-Fickian mechanism at conditions similar to 
psoriasis skin. The test indicated that gradually released drug 
may assist alleviate psoriasis by inhibiting hyperproliferation 
of keratinocyte.  
Manca et al prepared curcumin encapsulated nanovesicle 
using sodium hyaluronate 22. They studied the in vitro and in 
vivo permeation capacity of the prepared nanovesicles and 
compared to those of liposomes. TEM and XRD data displayed 
that the developed nanocarrier were spherical with 112-220 
nm size. Skin permeation test displayed an enhanced capacity 
of the nanovesicle to deposit drug molecules in a much faster 
way. Furthermore the nanovesicles were identified as 
biocompatible and safeguard human keratinocytes from the 
damage caused by oxidative stress and facilitated tissue 
remodeling. Finally, in vitro studies proved the capacity of the 
device to counteract 12-6-tetradecanoilphorhol created 
injuries and inflammation, reducing oedema development and 
furnishing skin re-epithelization. 
Martins et al developed solid-in-oil nanodispersion from HA 
and bovine serum albumin and evaluated its potential to be 
employed as transdermal device 23. The capacity of this 
nanodispersion to penetrate into deeper skin layers were 
confirmed by confocal and fluorescence microscopy. The 
article reported that the developed bovine serum albumin/HA 
disintegrated when it passes the SC. Noteworthy, the 
dispersion was found to be non-toxic in fibroblast and 
keratinocyte cells. The molecular weight of HA was too lower 
and hence less concentrated when compared with bovine 
serum albumin. This assisted HA to pass into deeper layers of 
skin. Therefore when the nanodispersion penetrates into skin 
layers bovine serum albumin could be hydrolyzed by 
proteases residing in the medium, which makes HA 
remarkably available and penetrate deeply. All these factors 
enhanced its availability and activity to act on skin targets.  
Wang et al prepared transdermal device based on HA 
encapsulated CuS nanoparticles. The transdermal permeation 
potential of the device was studied in details. The 
photothermal effect of the device at different concentration of 
HA-CuS was measured. The outcomes displayed that the 
device could potentially convert NIR irradiation to heat. In 
addition, in vivo experiment of laser activation of the device 
was carried out and the outcomes revealed that the device 
possessed excellent in vivo laser activation potential. 
Histological assay displayed that SC were disrupted by the 
application of device and exposed with 0.24 W/cm2 NIR 
irradiation. They further studied the capacity of the device to 
transport insulin across the skin and found that the blood 
glucose level of the treated mice was substantially reduced 
after the application of the device and irradiated with NIR. 
Smejkalov et al fabricated polymeric micelles which provided 
an auspicious method for the transdermal delivery of drug 
molecules 24. The polymeric micelle was prepared from oleic 
acid and HA. Permeation test revealed that the HA based 
micelle deposited three times and six times more drug, 
respectively in the epidermis and dermis, compared to that of 
non-polymeric micelle solution. The drug molecule in 
epidermis and dermis was visualized using confocal imaging. 
The articles detailed that the chief pathway for the 
permeation of drug was transcellular penetration. 
Wittig et al reported that HA was greatly compatible with 
biomolecules and can enhance the drug absorption 7. They 
studied the effect of HA hydrogel with variable molecular 
weight on transdermal permeation of bovine serum albumin. 
In addition, the research group proved the skin-HA 
interaction using fluorescence life time imaging microscopy 
and FTIR spectroscopy. In the tape-stripped skin without any 
barrier, only bovine serum albumin permeated into dermal 
skin layers. The permeation was limited to the epidermis 
when the skin was applied with both bovine serum albumin 
and HA. In the case of normal skin, an improvement in 
permeation into the epidermis was identified by the 
application of low lolecular weight HA. A close HA- bovine 
serum albumin was suggested by fluorescence energy transfer 
analysis. Furthermore FTIR studies displayed an inter-
conversion of keratin from α-helix to β-sheet. This improved 
the hydration of skin and interaction of lipids with HA 
produced a remarkable disruption in skin layers. Finally they 
concluded that HA behaved as a penetration enhancer for the 
transport of biomacromolecules in normal skin, chiefly 
mediated by the synergistic effect of co-transport, disruption 
of SC and improved hydration of skin.  
Berko and coworkers prepared cross linked HA system using 
diamine solution via carbodiimide technique and compared 
its skin penetration to that of linear HA 25. The tests results 
revealed that compared to linear HA, crosslinking of HA 
improved the hydration in deeper skin layers and enhanced 
its permeation through human epidermis. Furthermore, the 
dynamic rheological measurement revealed that the 
crosslinking changed the specific viscoelastic behavior of HA. 
Transepidermal water loss test showed that no skin irritation 
was observed after the application of crosslinked HA system. 
The investigation concluded that cross-linked HA could be 
used for the fabrication of transdermal drug delivery system 
with enhanced skin permeability. 
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The research group of Kong developed a transdermal device 
using HA and hydroxyethyl cellulose and used for the skin 
transportation of isoliquiritigenin 26. HA and hydroxyethyl 
cellulose was crossslinked using divinyl sulfone. The 
developed device significantly enhanced the skin permeability 
of isoliquiritigenin, ascribed to the improved water retention 
capacity of the HA based system, which reduced the skin 
barrier function through hydration of skin. The fabricated HA- 
hydroxyethyl cellulose system displayed stable viscoelastic 
properties and optimal adhesiveness. 
Xie et al prepared HA based ethosome and encapsulated with 
rhodamine B to evaluate the skin permeation 27. The 
developed transdermal device was spherical and displayed 
excellent dispersion and stability. Permeation test showed 
that HA containing ethosome displayed greater permeation 
compared to that of ethosome without HA. Fluorescence 
microscopic investigation indicated that the device permeated 
into dermal layer of skin. The enhancement effect shown by 
HA loaded ethosome was ascribed to its smaller size, 
hydration of HA and significant targeting to skin and skin 
appendages of the liposomal carriers. Furthermore the device 
was proven to be non-cytotoxic and can provide a swift and 
safer transdermal drug delivery system. 
Yang et al develop a receptor mediated transdermal system 
based on HA-human growth hormone conjugate 28. The 
conjugate was prepared by the reaction of aldehyde modified 
HA and the amine group of human growth hormone. 
Fluorescence microscopy markedly indicated the significantly 
improved permeation of the device through mice skin. 
Pharmacokinetic assay suggested that the device was 
permeated and reached the blood circulation by the receptor 
mediated transdermal delivery. The results proved the ability 
of the system to deliver protein drugs across the skin.  
Yue et al developed a HA based transdermal device for 
bupivacaine delivery. They conjugated HA and linolenic acid 
with propylene glycol 29. The device displayed small particle 
size of 150 nm, excellent stability and drug encapsulation 
efficiency of about 90 %. Compared with free bupivacaine, the 
device showed 2.5 fold enhancements in skin permeation and 
prolonged antinociceptive effect. 
HA based transdermal microneedles patches 
Choi et al fabricated microneedles comprising cross-linked HA 
by micromolding strategy 30. HA was cross-linked using 1,4-
butanediol diglycidylether. The study on swelling feature 
indicated that the swelling ratio of the cross-linked HA was 
significantly greater than that of pure HA. The developed 
microneedles have diameter of 90 µm and 10 µm, respectively 
at the base and tip. The permeation test revealed that a delay 
in HA degradation and sustained release profile can be 
obtained from the developed microneedle. Confocal 
microscopy confirmed the ability of the microneedle to 
deliver fluorescein into the skin. 
Kim et al developed a dissolving HA based MN device 
encapsulated with ascorbic acid-2-glucoside 31. The device 
was sterilized by gamma ray and electron beam. The 
microneedle architectures maintained their morphology after 
the application of electron beam and gamma rays. 
Nevertheless, the irradiation with gamma rays remarkably 
degraded the loaded ascorbic acid-2-glucoside while an 
electron beam of 40 kGy did not affect the release portrait and 
dissolution rate of microneedles. 
Matsuo et al detailed a vaccine therapy for Alzheimer’s 
diseases by employing microneedles fabricated from HA 32. 
The developed device potentially induced anti-Aβ1-42 
immuno response. Furthermore, the device has several 
benefits as it was simple, ease of application and minimally 
invasive vaccination strategy. Finally they proposed that 
certain modifications should be required for some downsides 
associated with the device. Wu et al fabricated a microneedle 
device based on HA loaded with sumatriptan succinate for 
migraine treatment 33. The devices conserved their skin 
penetration potential for 30 minutes after the application. In 
vitro test demonstrated a quick release profile of sumatriptan 
succinate from the device. Optical coherence tomography 
displayed that the device was efficiently penetrated the skin 
with no cracking or bending. The device was entirely 
dissolved in 60 minutes. The application of device resulted in 
a dose-dependent plasma sumatriptan succinate 
concentration. The delivery of sumatriptan succinate was 
similar to that from subcutaneous injection and high 
bioavailability which was significantly greater than that 
created by oral administration. 
Liu et al examined the features of extending-4 tip-loaded 
microneedles prepared from HA and further compared their 
potential with subcutaneous injection in diabetic rats 34. The 
release of encapsulated fluorescence isothiocyanate labeled 
dextran from the device was very quick, especially in the first 
30 s and within 600 s, most of the loaded molecules were 
released. Furthermore, glucose tolerance was improved and 
the release of insulin was improved when the device was 
applied. They reported that these outcomes were comparable 
with that of subcutaneous injection. The plasma concentration 
portraits suggested that the device can be employed as an 
alternative system for the treatment of type 2 diabetics. In 
another article Liu et al described the fabrication of insulin 
loaded HA microneedles and the features of the device such as 
stability, hygroscopy and drug release profile were examined 
35. The developed microneedles possessed 800 µm length with 
160 and 40 µm base and tip diameter, respectively. When the 
insulin loaded device was stored for 30 days at different 
temperatures, no significant loss in insulin was observed. 
More than 90 % of the loaded insulin was remained in the 
microneedles at all the studied temperature, which suggested 
the stability of the device. Furthermore, a remarkable 
enhancement in transepidermal water loss was identified 
after the insertion of microneedles and the damage produced 
by the device was reversible. In vitro permeation test 
indicated that insulin was swiftly released from the device. In 
vivo test displayed that a dose-dependent hypoglycemic effect 
and the transdermal delivery of insulin was identified after 
the insertion of patches. 
Yu et al prepared microneedle based on alginate and HA for 
transdermal insulin delivery 36. The device demonstrated 
superior mechanical strength to pierce deep into the skin and 
excellent degradability to deliver the encapsulated insulin. 
Confocal images confirmed that insulin could moderately 
diffuse to deeper skin layers. The loaded insulin in the device 
could maintain the high pharmacological activity, confirming a 
sustained hypoglycemic effect. The relative pharmacologic 
availability of insulin from the device was 90.5±6.8 %. while 
relative bioavailability was 92.9±7 %.  
CONCLUSIONS 
From the plethora of investigation involving HA in the last few 
years, it is obvious that HA have the capacity to potentially 
enhance the transdermal delivery of drug molecules. HA 
based hydrogel and nanoemulsion furnished potential value 
as transdermal device in addition to niosomes and 
transferosomes. HA based microneedles have also displayed 
appreciable guarantee in disturbing lipid layers of skin so as 
to improve the skin transportation. However little is studied 
about the mechanism in which HA enhances the skin 
permeation. Although HA promises to revolutionize the 
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transdermal drug delivery by enhancing the skin penetration, 
it is still to be completely exploited. Hence immense 
investigation therefore required to be performed into the 
modification of HA so as to ensure more effective targeted 
disruption of lipid layers while protecting deeper skin layers. 
Further investigation on HA will thus led in the development 
of novel patches that will be cheaper, painless and more 
effective in skin penetration. 
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